ANI Pharmaceuticals, Inc.
ANIP
$61.43
-$2.34-3.67%
03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 7.75% | 14.52% | 19.40% | 138.66% | 40.49% |
Total Receivables | 6.38% | -9.37% | 3.42% | -1.02% | 5.61% |
Inventory | 2.38% | 4.32% | 2.17% | 0.65% | -1.61% |
Prepaid Expenses | -8.43% | 63.97% | 30.34% | 20.59% | -20.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -96.35% | 0.00% | -33.21% | 2.95% | -29.06% |
Total Current Assets | 3.99% | 4.54% | 8.25% | 25.92% | 5.95% |
|
|||||
Total Current Assets | 3.99% | 4.54% | 8.25% | 25.92% | 5.95% |
Net Property, Plant & Equipment | 8.82% | 0.91% | -0.41% | 2.53% | 0.07% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -6.20% | -4.92% | -4.55% | -3.56% | -5.10% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -3.22% | 6.77% | 2.86% | 5.59% | -0.76% |
Total Assets | 1.12% | 1.63% | 3.56% | 12.30% | 0.68% |
|
|||||
Total Accounts Payable | 34.75% | 7.65% | 19.55% | -12.79% | 11.54% |
Total Accrued Expenses | -25.47% | 29.50% | 12.32% | 9.23% | -1.30% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -64.74% | 183.65% | 0.00% | 0.00% | 0.00% |
Total Finance Division Other Current Liabilities | -10.85% | -10.48% | 2.09% | -3.60% | 70.27% |
Total Other Current Liabilities | -10.85% | -10.48% | 2.09% | -3.60% | 70.27% |
Total Current Liabilities | -5.90% | 8.28% | 9.35% | -2.35% | 26.53% |
|
|||||
Total Current Liabilities | -5.90% | 8.28% | 9.35% | -2.35% | 26.53% |
Long-Term Debt | -0.07% | -0.07% | -0.07% | -0.07% | -0.07% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 22.96% | -21.83% | 11.16% | 293.59% | -12.96% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -10.12% | 17.58% | -12.21% | -9.27% | -62.18% |
Total Liabilities | -2.04% | 2.67% | 2.43% | -0.21% | 1.00% |
|
|||||
Common Stock & APIC | 1.85% | 1.50% | 2.23% | 21.33% | 1.11% |
Retained Earnings | 22.21% | 0.92% | 10.54% | 6.07% | 1.06% |
Treasury Stock & Other | -662.75% | -128.96% | -7.04% | 82.72% | -64.83% |
Total Common Equity | 4.44% | 0.67% | 4.94% | 30.19% | 0.30% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | 4.44% | 0.67% | 4.94% | 30.19% | 0.30% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.20% | 0.64% | 4.66% | 27.98% | 0.28% |
|